FDA Drug recall D-0508-2017
Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkum…
- FDA Drug
- Class III
- terminated
- Published 2017-03-08
On 2017-03-08 the FDA classified a Class III recall of Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkum… by Dr Reddy S Laboratories, citing failed dissolution specifications - low dissolution results at S3 stage.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0508-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-02-15 |
| Published | 2017-03-08 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Dr Reddy S Laboratories |
| Distribution | US |
Product
Zenatane (isotretinoin) capsules, 30 mg, packaged in 30-count cartons (3 x 10 blister cards), Rx Only, Manufactured By:Cipla Limited Kurkumbh Village Pune 413802 India, Manufactured For: Dr. Reddy's Laboratories, Bachupally 500 090 India, NDC 5511-113-81
Reason
Failed dissolution specifications - low dissolution results at S3 stage.
Identifiers
| code_info | Lot # KB60036, Exp 12/17 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0508-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.